Pharma sector funds invest in pharmaceutical manufacturers, API makers, hospital chains, and healthcare companies. The sector is considered somewhat defensive — demand for medicines doesn't disappear in downturns. But it's also subject to regulatory risk from the US FDA and pricing pressure in export markets.
| Fund Name | AUM | 1Y Returns | TER(%) | |
|---|---|---|---|---|
| Category Average | ₹2,271 Cr | +19.96% | 1.09 | |
| Nippon India Pharma FundVery High | ₹9,479 Cr | +13.1% | 0.99 | View → |
| ICICI Prudential Healthcare FundVery High | ₹6,952 Cr | +9.0% | 1.31 | View → |
| SBI Healthcare Opportunities FundVery High | ₹5,796 Cr | +23.1% | 1.04 | View → |
| DSP Healthcare FundVery High | ₹3,835 Cr | +17.2% | 0.73 | View → |
| Mirae Asset Healthcare FundVery High | ₹3,555 Cr | +21.9% | 0.61 | View → |
| HDFC Pharma and Healthcare FundVery High | ₹3,311 Cr | +28.6% | 1.08 | View → |
| Tata India Pharma & Healthcare FundVery High | ₹1,565 Cr | +10.6% | 1.00 | View → |
| UTI Healthcare FundVery High | ₹1,444 Cr | +18.9% | 1.26 | View → |
| Aditya Birla Sun Life Pharma & Healthcare FundVery High | ₹1,103 Cr | +19.6% | 1.02 | View → |
| WhiteOak Capital Pharma and Healthcare FundVery High | ₹902 Cr | +24.6% | 1.13 | View → |
| Kotak Healthcare FundVery High | ₹759 Cr | +28.9% | 1.09 | View → |
| Baroda BNP Paribas Health and Wellness FundVery High | ₹507 Cr | +12.8% | 1.56 | View → |
| Quant Healthcare FundVery High | ₹428 Cr | +23.7% | 1.49 | View → |
| Bajaj Finserv Healthcare FundVery High | ₹406 Cr | +25.7% | 0.90 | View → |
| Bandhan Healthcare FundVery High | ₹327 Cr | — | 1.22 | View → |
| ITI Pharma & Healthcare FundVery High | ₹276 Cr | +14.5% | 0.92 | View → |
| PGIM India Healthcare FundVery High | ₹125 Cr | +27.5% | 0.93 | View → |
| LIC MF Healthcare FundVery High | ₹103 Cr | +19.6% | 1.42 | View → |